157 related articles for article (PubMed ID: 22754369)
1. Revealing the anti-tumor effect of artificial miRNA p-27-5p on human breast carcinoma cell line T-47D.
Tseng CW; Huang HC; Shih AC; Chang YY; Hsu CC; Chang JY; Li WH; Juan HF
Int J Mol Sci; 2012; 13(5):6352-6369. PubMed ID: 22754369
[TBL] [Abstract][Full Text] [Related]
2. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
[TBL] [Abstract][Full Text] [Related]
3. miR-6883 Family miRNAs Target CDK4/6 to Induce G
Lulla AR; Slifker MJ; Zhou Y; Lev A; Einarson MB; Dicker DT; El-Deiry WS
Cancer Res; 2017 Dec; 77(24):6902-6913. PubMed ID: 29061672
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
6. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
7. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
Feng T; Xu D; Tu C; Li W; Ning Y; Ding J; Wang S; Yuan L; Xu N; Qian K; Wang Y; Qi C
Tumour Biol; 2015 Aug; 36(8):5987-97. PubMed ID: 25731732
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
[TBL] [Abstract][Full Text] [Related]
9. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S
FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
11. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
Li X; Han X; Yang J; Sun J; Wei P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
[TBL] [Abstract][Full Text] [Related]
12. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
13. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
Yu Z; Wang C; Wang M; Li Z; Casimiro MC; Liu M; Wu K; Whittle J; Ju X; Hyslop T; McCue P; Pestell RG
J Cell Biol; 2008 Aug; 182(3):509-17. PubMed ID: 18695042
[TBL] [Abstract][Full Text] [Related]
14. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
15. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
Xia H; Long J; Zhang R; Yang X; Ma Z
Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
[TBL] [Abstract][Full Text] [Related]
16. miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE.
Luo T; Yan Y; He Q; Ma X; Wang W
Oncol Rep; 2018 Jun; 39(6):2906-2914. PubMed ID: 29620238
[TBL] [Abstract][Full Text] [Related]
17. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
[TBL] [Abstract][Full Text] [Related]
18. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
19. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
